Phibro Animal Health PAHC
NASDAQ PAHC
$35.02 -0.95 (-2.64%)
At close: Nov 16, 2026 · 4:00 PM EST

Phibro Animal Health (PAHC) Liabilities and Shareholders Equity (2013 - 2026)

Updated

Phibro Animal Health (PAHC) reported Liabilities and Shareholders Equity of $1.51 billion for fiscal Q1 2027 (quarter ended Sep 30, 2026), up 9.3% from $1.39 billion a year earlier and up 0.9% from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends

At the end of FY2026 (ended Jun 30, 2026), Phibro Animal Health posted Liabilities and Shareholders Equity of $1.5 billion, up 10.3% from FY2025.

  • Liabilities and Shareholders Equity has increased for 12 consecutive fiscal years, with a five-year compound annual growth rate of 12.3% (FY2021 to FY2026).
  • By fiscal year, Liabilities and Shareholders Equity came in at $1.36 billion in FY2025 (+38.6%), $982.18 million in FY2024 (+1.1%), $971.4 million in FY2023 (+4.3%) and $931.7 million in FY2022 (+10.7%).
  • The fiscal Q1 2027 figure ranks as the highest quarterly Liabilities and Shareholders Equity in data going back to fiscal Q4 2013.
  • Year over year, Liabilities and Shareholders Equity has now increased in each of the last 24 quarters, with growth averaging 23.4% over the last eight quarters.
  • Across the past five years, year-over-year growth in Liabilities and Shareholders Equity ran from 0.2% in fiscal Q1 2025 to 43.4% in fiscal Q1 2026.
  • Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $1.5 billion (Q4 2026), $1.45 billion (Q3 2026) and $1.41 billion (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 197.43 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 147.68 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 119.92 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 51.41 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 205.00 Bn
10 Phibro Animal Health 1.42 Bn 1.11 Bn 128.54 Mn 1.51 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.51 Bn
Jun 30, 2026 1.50 Bn
Mar 31, 2026 1.45 Bn
Dec 31, 2025 1.41 Bn
Sep 30, 2025 1.39 Bn
Jun 30, 2025 1.36 Bn
Mar 31, 2025 1.32 Bn
Dec 31, 2024 1.29 Bn
Sep 30, 2024 966.29 Mn
Jun 30, 2024 982.18 Mn
Mar 31, 2024 979.04 Mn
Dec 31, 2023 972.71 Mn
Sep 30, 2023 964.52 Mn
Jun 30, 2023 971.40 Mn
Mar 31, 2023 965.43 Mn
Dec 31, 2022 961.83 Mn
Sep 30, 2022 948.38 Mn
Jun 30, 2022 931.70 Mn
Mar 31, 2022 916.18 Mn
Dec 31, 2021 848.96 Mn
API Access

Phibro Animal Health Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PAHC&period=max&api_key=YOUR_API_KEY